These data demonstrated that the neuroprotective effects of astroglial activation took place primarily at the early stage of tauopathies by enhancing endocytosis and subsequently, triggering intensive lysosomal-mediated degradation of abnormal tau species. Here, MAPT is linked to tauopathy.